Enzastaurin: all 50 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™CompletedNCT03263026Phase 3Results posted
• A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or LymphomaCompletedNCT01432951Phase 1Results posted
• A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of WarfarinCompletedNCT01388335Phase 1Results posted
• A Study for Participants With Relapsed Cutaneous T-Cell LymphomaCompletedNCT00744991Phase 2Results posted
• A Study for Patients That Have Been Previously Been Treated in Waldenstrom's Macroglobulinemia or Multiple MyelomaCompletedNCT00718419Phase 2Results posted
• A Study for Participants With Metastatic Renal Cell CarcinomaCompletedNCT00709995Phase 2Results posted
• Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon CancerCompletedNCT00612586Phase 2Results posted
• Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant GliomasCompletedNCT00586508Phase 2Results posted
• A Study for Patients With Non-Hodgkin's LymphomasCompletedNCT00542919Phase 2Results posted
• Study for Participants With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + PlaceboTerminatedNCT00538681Phase 2Results posted
• Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast CancerTerminatedNCT00536939Phase 2Results posted
• Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With ChemotherapyCompletedNCT00533429Phase 2Results posted
• Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung CancerCompletedNCT00530621Phase 2Results posted
• Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed GlioblastomaCompletedNCT00509821Phase 2Results posted
• A Study of Enzastaurin in Participants With Follicular LymphomaCompletedNCT00475644Phase 2Results posted
• A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer PatientsCompletedNCT00466440Phase 2Results posted
• A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung CancerCompletedNCT00452413Phase 1/2Results posted
• Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast CancerCompletedNCT00451555Phase 2Results posted
• A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP OnlyCompletedNCT00451178Phase 2Results posted
• Enzastaurin in Combination of Capecitabine to Treat Breast CancerTerminatedNCT00437294Phase 2Results posted
• A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal CancerCompletedNCT00437268Phase 2Results posted
• Chemotherapy for Participants With LymphomaCompletedNCT00436280Phase 2Results posted
• Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and ChemotherapyCompletedNCT00428714Phase 2Results posted
• Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal CancerCompletedNCT00420381Phase 2Results posted
• Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation TherapyCompletedNCT00415363Phase 2Results posted
• A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former SmokersCompletedNCT00414960Phase 2Results posted
• Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00407758Phase 2Results posted
• Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) PatientsCompletedNCT00402116Phase 1/2Results posted
• Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")CompletedNCT00391118Phase 2Results posted
• PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily EnzastaurinCompletedNCT00332202Phase 3Results posted
• An Open Label Study of Oral Enzastaurin in Participants With CancerCompletedNCT00309140Phase 2Results posted
• First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00308750Phase 2Results posted
• Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic CancerCompletedNCT00267020Phase 2Results posted
• Enzastaurin for Patients With Metastatic Colorectal CancerCompletedNCT00192114Phase 2Results posted
• Oral Enzastaurin in Participants With Relapsed Mantle Cell LymphomaCompletedNCT00088205Phase 2Results posted
• A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.CompletedNCT00042666Phase 2Results posted
• Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome.SuspendedNCT05463679Phase 3
• A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1CompletedNCT03776071Phase 3
• A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent GliomasCompletedNCT01445119Phase 1
• Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate CancerWithdrawnNCT00685633Phase 2
• Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic CancerCompletedNCT00550927Phase 1
• Enzastaurin and Temozolomide in Treating Patients With Primary GliomasStatus unknownNCT00516607Phase 1
• Enzastaurin in Treating Young Patients With Refractory Primary CNS TumorsCompletedNCT00503724Phase 1
• Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung CancerWithdrawnNCT00469976Phase 2
• A Study of Enzastaurin in Patients With LeukemiaCompletedNCT00452257Phase 1
• Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane ChemotherapyCompletedNCT00386087Phase 2
• Enzastaurin Versus Lomustine in GlioblastomaCompletedNCT00295815Phase 3
• A Study of LY317615 in Patients With Brain TumorsCompletedNCT00190723Phase 2
• Enzastaurin to Treat Recurrent Brain TumorTerminatedNCT00108056Phase 1
• Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.CompletedNCT00105092Phase 2

← Enzastaurin overview